Log in to save to my catalogue

Agonist binding affinity determines palmitoylation of the glucagon-like peptide-1 receptor and its f...

Agonist binding affinity determines palmitoylation of the glucagon-like peptide-1 receptor and its f...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2153840188

Agonist binding affinity determines palmitoylation of the glucagon-like peptide-1 receptor and its functional interaction with plasma membrane nanodomains in pancreatic beta cells

About this item

Full title

Agonist binding affinity determines palmitoylation of the glucagon-like peptide-1 receptor and its functional interaction with plasma membrane nanodomains in pancreatic beta cells

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2018-12

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

The glucagon-like peptide-1 receptor (GLP-1R), a key pharmacological target in type 2 diabetes and obesity, is known to undergo palmitoylation by covalent ligation of an acyl chain to cysteine 438 in its carboxyl-terminal tail. Work with other GPCRs indicates that palmitoylation can be dynamically regulated to allow receptors to partition into plas...

Alternative Titles

Full title

Agonist binding affinity determines palmitoylation of the glucagon-like peptide-1 receptor and its functional interaction with plasma membrane nanodomains in pancreatic beta cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2153840188

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2153840188

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/492496